STERIS PLC (NYSE:STE) Shares Sold by US Bancorp DE
US Bancorp DE decreased its stake in STERIS PLC (NYSE:STE) by 9.7% during the second quarter, Holdings Channel reports. The firm owned 10,388 shares of the medical equipment provider’s stock after selling 1,113 shares during the period. US Bancorp DE’s holdings in STERIS PLC were worth $846,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of the company. Bragg Financial Advisors Inc purchased a new position in STERIS PLC during the first quarter worth about $1,159,000. Louisiana State Employees Retirement System increased its position in STERIS PLC by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 21,400 shares of the medical equipment provider’s stock worth $1,486,000 after buying an additional 300 shares in the last quarter. Legal & General Group Plc increased its position in STERIS PLC by 31.0% in the first quarter. Legal & General Group Plc now owns 56,190 shares of the medical equipment provider’s stock worth $3,902,000 after buying an additional 13,294 shares in the last quarter. Morgan Stanley increased its position in STERIS PLC by 28.3% in the first quarter. Morgan Stanley now owns 266,537 shares of the medical equipment provider’s stock worth $18,514,000 after buying an additional 58,776 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its position in STERIS PLC by 57.5% in the first quarter. Russell Investments Group Ltd. now owns 132,035 shares of the medical equipment provider’s stock worth $9,171,000 after buying an additional 48,188 shares in the last quarter. 91.80% of the stock is currently owned by institutional investors and hedge funds.
STERIS PLC (NYSE STE) traded up 0.35% on Friday, reaching $84.94. The company had a trading volume of 358,659 shares. The stock has a 50 day moving average of $82.58 and a 200 day moving average of $75.07. STERIS PLC has a 12 month low of $63.80 and a 12 month high of $87.49. The firm has a market capitalization of $7.24 billion, a PE ratio of 60.76 and a beta of 1.33.
STERIS PLC (NYSE:STE) last announced its quarterly earnings data on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.80 by $0.05. STERIS PLC had a return on equity of 11.39% and a net margin of 4.63%. The firm had revenue of $608 million for the quarter, compared to analysts’ expectations of $597.66 million. During the same quarter in the prior year, the firm posted $0.79 earnings per share. STERIS PLC’s revenue for the quarter was down 4.8% compared to the same quarter last year. On average, analysts anticipate that STERIS PLC will post $4.06 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th will be paid a dividend of $0.31 per share. The ex-dividend date is Friday, August 25th. This represents a $1.24 annualized dividend and a yield of 1.46%. This is a boost from STERIS PLC’s previous quarterly dividend of $0.28. STERIS PLC’s dividend payout ratio is presently 80.00%.
TRADEMARK VIOLATION NOTICE: This article was posted by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this article can be viewed at https://www.watchlistnews.com/steris-plc-nyseste-shares-sold-by-us-bancorp-de/1479728.html.
STE has been the topic of a number of research reports. KeyCorp upgraded STERIS PLC from a “sector weight” rating to an “overweight” rating and set a $89.00 price target on the stock in a research note on Wednesday, May 3rd. Wellington Shields downgraded STERIS PLC from a “gradually accumulate” rating to a “hold” rating in a research note on Monday, June 5th. Zacks Investment Research upgraded STERIS PLC from a “sell” rating to a “hold” rating in a research note on Friday, June 23rd. BidaskClub downgraded STERIS PLC from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Finally, Raymond James Financial, Inc. raised their price target on STERIS PLC from $90.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $86.75.
In other STERIS PLC news, VP Sudhir K. Pahwa sold 800 shares of the company’s stock in a transaction that occurred on Thursday, May 25th. The stock was sold at an average price of $77.28, for a total transaction of $61,824.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Sudhir K. Pahwa sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $79.07, for a total value of $237,210.00. Following the sale, the vice president now owns 22,047 shares in the company, valued at approximately $1,743,256.29. The disclosure for this sale can be found here. Insiders have sold 33,084 shares of company stock worth $2,668,633 in the last 90 days. 2.55% of the stock is currently owned by insiders.
About STERIS PLC
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS PLC (NYSE:STE).
Receive News & Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.